AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 62 min read$NVMI

Waisman Gabriel sold $1.5M of NVMI

Waisman Gabriel (CEO & President) sold 2,966 shares of NOVA LTD. (NVMI) at $501.30 ($1.49M total) on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Waisman Gabriel
Published Jul 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$NVMI
Neutral
high confidence
Mentioned
$NVMI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but 10b5-1 plans generally reduce interpretability as a forward-looking signal.

02

Market read

A CEO open-market sale of about $1.49M is disclosed, but the 10b5-1 structure suggests limited fundamental implications.

03

What to watch

The article provides no context on total holdings changes beyond the post-transaction figure, and no link to performance or upcoming events.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-06, sale dated 2026-07-02

Background

The article is an SEC Form 4 insider transaction disclosure for NOVA Ltd. (NVMI).

Company-level read

Ticker impact

$NVMINeutralHigh confidence
Context

Form 4 shows CEO Gabriel Waisman sold 2,966 shares of NVMI at $501.30 on 2026-07-02 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is an open-market sale by the CEO, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, deal, or regulatory action.

Market effects

Sector

No clear sector read-through from a single 10b5-1 insider sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales under 10b5-1 can be purely liquidity-driven and may not signal reduced confidence.

Key entities

  • issuer
    NOVA Ltd.

    Company subject of the Form 4 insider transaction disclosure.

  • insider
    Waisman Gabriel

    CEO and President who executed an open-market sale under a 10b5-1 plan.

Read at source← All news

Related articles

JUL 29
$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

globes.co.il4 min
JUL 2
$NVMIMed

Nova WMC™ Expanding Adoption Across the Most Advanced Packaging Processes

Nova (NASDAQ: NVMI) said a leading global foundry customer selected its Nova WMC™ platform as tool-of-record for multi-layer measurement in advanced packaging. The company expects the win to support multiple production flows and notes accelerating WMC™ adoption across memory and foundry customers. Nova cited modular design and nanometer-level large-area scanning throughput.

prnewswire.com3 min
JUN 1
$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).

en.globes.co.il3 min